Pharma & Biotech

Iovance Biotherapeutics shares experienced a dramatic rally on Friday, closing the trading session with a substantial 13% gain at $2.49....

Shares of Viking Therapeutics experienced a dramatic sell-off after the biopharmaceutical company released Phase 2 trial results for its oral...

After an extended period of decline, Nurix Therapeutics Inc. shares demonstrated a significant resurgence, propelled by a substantial increase in...

TG Therapeutics is demonstrating extraordinary momentum, largely driven by the remarkable performance of its flagship therapy. While numerous pharmaceutical companies...

While Eli Lilly continues to dominate headlines with its blockbuster GLP-1 portfolio, a significant development is emerging from its oncology...

Genomics leader Illumina finds itself navigating a complex strategic landscape. The company's latest quarterly results reveal continued revenue pressure, even...

Sellas Life Sciences is generating significant attention with two advanced cancer therapies showing compelling clinical results. The biotechnology firm's innovative...

After an extended period of decline, Baxter International Inc. shares have demonstrated a surprising uptick, posting significant gains in the...

Pliant Therapeutics Inc. is facing a severe market downturn as its share price experiences significant erosion. This steep decline comes...

Xtant Medical, a specialist in the medical technology sector, is navigating a complex strategic pivot. The company recently announced record-breaking...